Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports

24.04.2024 | Nuclear Cardiology (V Dilsizian, Section Editor)

Chagas Cardiomyopathy and Myocardial Sympathetic Denervation

verfasst von: Leonardo Pippa Gadioli, André Schmidt, Benedito Carlos Maciel, Gustavo Jardim Volpe, Marcus Vinicius Simões, José Antonio Marin-Neto

Erschienen in: Current Cardiology Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

More than a century since its discovery, the pathogenesis of Chagas heart disease (CHD) remains incompletely understood. The role of derangements in the autonomic control of the heart in triggering malignant arrhythmia before the appearance of contractile ventricular impairment was reviewed.

Recent Findings

Although previous investigations had demonstrated the anatomical and functional consequences of parasympathetic dysautonomia upon the heart rate control, only recently, coronary microvascular disturbances and sympathetic denervation at the ventricular level have been reported in patients and experimental models of CHD, exploring with nuclear medicine methods their impact on the progression of myocardial dysfunction and cardiac arrhythmias.

Summary

More important than parasympathetic impaired sinus node regulation, recent evidence indicates that myocardial sympathetic denervation associated with coronary microvascular derangements is causally related to myocardial injury and arrhythmia in CHD. Additionally, 123I-MIBG imaging is a promising tool for risk stratification of progression of ventricular dysfunction and sudden death.
Literatur
1.
2.
3.
4.
•• Marin-Neto JA, Maciel BC, Cunha-Neto E, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115:1109–11231. This scientific statement discusses the main pathogenetic mechanisms to explain the development of chronic Chagas heart disease.PubMedCrossRef
5.
Chagas C, Vilella E. Cardiac form of American trypanosomiasis. Mem Inst Oswaldo Cruz. 1922;14:5–61.CrossRef
6.
Köberle F. Patogenia da moléstia de Chagas. Estudo dos órgãos musculares ocos. Rev Goiana Med. 1957;3:155–62.
7.
Köberle F. Cardiopathia parasympaticopriva München Med Wschr. 1959;101:1308–10.
8.
Andrade Z. Anatomia patológica da doença de Chagas. Ver Goiana Med. 1958;4:103–19.
9.
Chapadeiro E, Lopes ERFEL. Desnervação parassimpática e hipertrofia do mocáradio em chagásicos crônicos. Ver Inst Med Trop S Paulo. 1967;9:40–2.
10.
Mott KE, Hagstrom JWC. The pathologic lesions of the cardiac autonomic nervous system in chronic Chagas’ myocarditis. Circulation. 1965;31:273–86.PubMedCrossRef
11.
Ribeiro-Jorge PA, Pires M, Carvalhal S. Sobre os neurônios do coração e a coronariografia post-mortem na cardiopatia chagásica crônica. Arq Bras Cardiol. 1979;23:101–8.
12.
Lopes ER, Chapadeiro E, Almeida HO, Rocha A. Contribuição ao estudo da anatomia patológica dos corações de chagásicos falecidos subitamente. Ver Soc Bras Med Trop. 1975;9:269–82.CrossRef
13.
Alcântara FG. Sistema neurovegetativo do coração na moléstia de Chagas experimental. Rev Goiana Med. 1961;7:111–8.
14.
Tafuri WL, Breneer Z. Lesões do Sistema nervoso autônomo do camundongo albino na tripanossomíase cruzi experimental. Hospital (RJ). 1966;69:371–80.
15.
Suárez JA. Los ganglios neurovegetativos intracardiacos em la patogenia de la miocarditis chagásica (Estudio histopatológico humano y experimental). Gaz Med Bahia. 1969;69:73–81.
16.
DeSouza MM, Andrade SG, Barbosa AA Jr, Macedo dos Santos RT, Ferreira Alves VA, Andrade ZA. Trypanosoma cruzi strains and autonomic nervous system pathology in experimental Chagas disease. Mem Inst Oswaldo Cruz. 1996;91:2117–24.
17.
Machado CR, Caliari MV, de Lana M, Tafuri WL. Heart autonomic innervation during the acute phase of experimental American trypanosomiasis in dogs. Am J Trop Med Hyg. 1998;59:492–6.PubMedCrossRef
18.
Amorim DS, Marin-Neto JA. Functional alterations of the autonomic nervous system in Chagas’heart disease. Sao Paulo Med J. 1995;113:772–84.PubMedCrossRef
19.
Amorim DS, Manço JC, Gallo L Jr, Marin-Neto JA. Chagas’ heart disease as an experimental model for studies of cardiac autonomic function in man. Mayo Clin Proc. 1982;57:48–60.PubMed
20.
Oliveira JSM. A natural human model of intrinsic heart nervous system denervation: Chagas’ cardiopathy. Am Heart J. 1985;110:1092–8.PubMedCrossRef
21.
Köberle F. Enteromegaly and cardiomegaly in Chagas’disease Gut. 1963;4:399–405.
22.
Adad SJ, Cançado CG, Etchebehere RM, Teixeira VP, Gomes UA, Chapadeiro E, Lopes ER. Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neurons analysis. Virchows Archives. 2001;438:254–8.CrossRef
23.
Meneghelli UG. Chagasic enteropathy. Rev Soc. Med Trop. 2004;37:252–60.
24.
Oliveira RB, Ballart C, Abràs A, Gállego M, Marin-Neto JA. Chagas disease. An unknown and neglected disease. In : Chagas disease. A neglected tropical disease. Editors : Pinazo-Delgado MJ, Gascón J. © Springer Nature Switzerland AG 2020. https://​doi.​org/​10.​1007/​978-3-030-44054-1
25.
Marin Neto JA, Gallo L Jr, Manco JC, Rassi A, Amorim DS. Mechanisms of tachycardia on standing: studies in normal individuals and in chronic Chagas’heart patients. Cardiovasc Res. 1980;14(9):541–50.PubMedCrossRef
26.
Emdin M, Marin-Neto JA, Carpeggiani C, Maciel BC, Macerata A, Pintya AO, Michelassi C, Gallo l Jr, Pola S, Marchesi C, L’abbate A. Heart rate variability and cardiac denervation in Chagas’disease. Journal of Ambulatory Monitoring. 1992;5(2–3):251–7.
27.
•• Silva LEV, Moreira HT, Oliveira MM, Cintra LSS, Salgado HC, Fazan R Jr, et al. Heart rate variability as a biomarker in patients with chronic Chagas cardiomyopathy with or without concomitant digestive involvement and its relationship with the Rassi score. Biomed Eng Online. 2022;21:44. This article explores the role of dysautonomia in CCC, particularly its impact on digestive organic involvement. The study focuses on the use of heart rate variability (HRV) as a tool for stratifying the risk of death in CCC patients.PubMedPubMedCentralCrossRef
28.
Silva CP, Del Carlo CH, Oliveira Junior MT, Scipioni A, Strunz-Cassaro C, Ramirez JA, Pereira Barretto AC. Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy? Arq Bras Cardiol. 2008;91(6):358–62.PubMed
29.
30.
Moraes DN, Nascimento BR, Lima-Costa MF, Soares CPM, Ribeiro ALP. Vagal dysautonomia in patients with Chagas disease and mortality: 14-year results of a population cohort of the elderly. J Electrocardiol. 2023;14(82):1–6.
31.
Raffel DM, Wieland DM. Development of mIBG as a cardiac innervation imaging agent. JACC Cardiovasc Imaging. 2010;3(1):111–6.PubMedCrossRef
32.
Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3(1):92–100.PubMedCrossRef
33.
Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86(9):975–81.PubMedCrossRef
34.
Marino VSP, Dumont SM, Mota LDG, Braga DS, Freitas SS, Moreira MDCV. Sympathetic Dysautonomia in heart failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients. Arq Bras Cardiol. 2018;111(2):182–90.PubMedPubMedCentral
35.
•• Gadioli LP, Miranda CH, Marin-Neto JA, Volpe GJ, Filho ACLB, Filho AP, et al. Regional myocardial sympathetic denervation precedes the development of left ventricular systolic dysfunction in chronic Chagas’ cardiomyopathy. J Nucl Cardiol. 2022;29:3166–76. This study showed a correlation between the extent of sympathetic denervation and the severity of incident ventricular arrhythmia, indicating a potential role of MIBG imaging in risk stratification of sudden death in Chagas’ cardiomyopathy.PubMedCrossRef
36.
Barizon GC, Simões MV, Schmidt A, Gadioli LP, Murta-Junior LO. Relationship between microvascular changes, autonomic de- nervation, and myocardial fibrosis in Chagas cardiomyopathy: evaluation by MRI and SPECT imaging. J Nucl Cardiol. 2018.
37.
Lemos de Oliveira LF, Thackeray JT, Marin Neto JA, Dias Romano MM, Vieira de Carvalho EE, Mejia J, Tanaka DM, Kelly da Silva G, Abdalla DR, Malamut C, Bengel FM, de Lourdes Higuchi M, Schmidt A, Cunha-Neto E, Simões MV. Regional myocardial perfusion disturbance in experimental chronic Chagas cardiomyopathy. J Nucl Med. 2018;59(9):1430–6.PubMedCrossRef
38.
Tanaka DM, Simões MV, Marin-Neto JA. Coronary microvascular dysfunction due to Chagas disease: where are we now? Expert Rev Cardiovasc Ther. 2023;21(6):379–87.PubMedCrossRef
39.
Marin-Neto JA, Simões MV, Ayres-Neto EM, Attab-Santos JL, Gallo L Jr, Amorim DS, Maciel BC. Studies of the coronary circulation in Chagas’ heart disease. Sao Paulo Med J. 1995;113(2):826–34.PubMedCrossRef
40.
de Oliveira SF, Pedrosa RC, Nascimento JH, Campos de Carvalho AC, Masuda MO. Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation. 1997;96(6):2031–7.PubMedCrossRef
41.
Masuda MO, Levin M, De Oliveira SF, Dos Santos Costa PC, Bergami PL, Dos Santos Almeida NA, Pedrosa RC, Ferrari I, Hoebeke J, Campos de Carvalho AC. Functionally active cardiac antibodies in chronic Chagas’ disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J. 1998;12(14):1551–8.PubMedCrossRef
42.
Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arq Bras Cardiol. 2001;76:75–96.PubMedCrossRef
43.
44.
Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simoes MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I- metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011;52:504–10.PubMedCrossRef
45.
Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC, et al. The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy: Chagas disease, denervation and arrhythmia. J Nucl Cardiol. 2018;25:75–83.PubMedCrossRef
46.
de Brito ASX, Moll-Bernardes RJ, Pinheiro MVT, Camargo GC, Siqueira FPR, Oliveira RS, Glavam AP, de Almeida SA, de Holanda MT, Sangenis LHC, Mendes FSNS, Rosado-de-Castro PH, de Sousa AS. Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy. J Nucl Cardiol. 2023;30(6):2379–88.PubMedCrossRef
47.
Agostini D, Verberne HJ, Burchert W, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535–46.PubMedCrossRef
48.
Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in chronic heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol. 2010;55:2212–21.PubMedCrossRef
49.
Kuwahara Y, Tamaki N, Nakata T, Yamashina S, Yamazaki J. Determi- nation of the survival rate in patients with congestive heart failure stratified by 123I-MIBGimaging: a meta- analysis from the studied performed in Japan. Ann Nucl Med. 2011;25:101–7.CrossRef
50.
Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, Matsui T, Matsuo S, Travin MI, Jacobson AF. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long- term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6(7):772–84.PubMedCrossRef
51.
Gadioli LP. “Myocardial perfusion scintigraphy to assess the extent of sympathetic denervation and its correlation with the incidence of left ventricular contractile dysfunction and the incidence of serious clinical events”. PhD thesis approved on the 06/29th, 2015. University of São Paulo, Brazil.
52.
Oliveira LFL, Thackeray JT, Tanaka DM, Fabricio CG, Carvalho EEV, Barros-Filho ACL, Cosenza NN, Ricke-Hoch DHKM, Romano MMD, Mejia JC, Schirmer BGA, Malamut C, Cunha-Neto E, Marin-Neto JÁ, Bengel FM, Simões MV. Increased 99mTc-Sestamibi washout is related to myocardial inflammation in chronic Chagas cardiomyopathy. J Nucl Med (in press).
Metadaten
Titel
Chagas Cardiomyopathy and Myocardial Sympathetic Denervation
verfasst von
Leonardo Pippa Gadioli
André Schmidt
Benedito Carlos Maciel
Gustavo Jardim Volpe
Marcus Vinicius Simões
José Antonio Marin-Neto
Publikationsdatum
24.04.2024
Verlag
Springer US
Erschienen in
Current Cardiology Reports
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-024-02057-y

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise